- Home
- NOW vs BMY Comparison
NOW vs BMY Comparison
Compare NOW & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NOW | BMY |
|---|---|---|
| Founded | 2004 | 1887 |
| Country | United States | United States |
| Employees | N/A | 32500 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.2B | 123.7B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | NOW | BMY |
|---|---|---|
| Price | $89.90 | $59.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 32 | 16 |
| Target Price | ★ $229.65 | $61.75 |
| AVG Volume (30 Days) | ★ 12.0M | 9.9M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.26% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | ★ $1,933,026,000.00 | N/A |
| Revenue This Year | $21.54 | N/A |
| Revenue Next Year | $18.39 | N/A |
| P/E Ratio | $58.34 | ★ $17.26 |
| Revenue Growth | ★ 39.02 | N/A |
| 52 Week Low | $96.96 | $42.52 |
| 52 Week High | $1,057.39 | $62.89 |
Technical Indicators
Market Signals| Indicator | NOW | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 25.27 | 50.83 |
| Support Level | N/A | $59.23 |
| Resistance Level | $110.85 | $62.39 |
| Average True Range (ATR) | 4.89 | 1.29 |
| MACD | -0.35 | -0.01 |
| Stochastic Oscillator | 3.25 | 52.64 |
Price Performance
Historical ComparisonAbout NOW ServiceNow Inc.
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.